COVID-19: impact on the research line of biotech firms in Spain 2020
According to a survey carried out by the Spanish Bioindustry Association (ASEBIO), more than 45 percent of the biotech firms in Spain changed their research line during 2020 to COVID-19 related topics. The remaining 54.6 percent stated that COVID-19 had no impact on their research line.
